top of page
Prescription Drugs

Healthcare, Lifesciences & Pharmaceuticals

Healthcare: The Firm provides a wide range of services to clients in the health care sector, covering the whole gamut from pharmaceuticals to hospitals and clinics through medical devices companies. The Firm’s expertise in this sector ranges from providing advice in respect of a pharmaceutical company’s establishment and operations; a wide range of domestic and international commercial transactions, including, distribution, warehouse and logistics agreements, materials transfer agreements, and the development, manufacture and marketing of formulations; intellectual property protection; market authorization agreements; to providing sector focused regulatory advise whether in the context of foreign investment or otherwise.  The Firm also assists clients in the negotiation and finalization of joint ventures, acquisitions or collaborations, which are critical and typical for a pharmaceutical company.  


Life Sciences & Pharmaceuticals:  The Firm’s knowledge and expertise in the healthcare, life sciences and allied sectors allows us to provide a wide range of services in these sectors, ranging from assistance with contracts involving healthcare professionals, drug manufacturers, clinical research, and supply of products, to advising on issues relating to regulatory compliance and intellectual property rights, among others.

We have drafted sector-specific agreements such as R&D collaboration agreements, supply agreements, quality agreements, patent transfer, and revenue sharing agreements, doctor engagement contracts etc.




Key Contacts


Ekta Bahl




Neha Mirajgaoker




Vineetha MG





“Samvad Partners offers broad expertise across transactions, regulatory issues, governance, and intellectual property, working with clients including drug manufacturers, biotech companies, hospitals, and healthcare providers on a wide range of complex, often cross-border matters. The firm is noted for its capabilities in cross-border M&A and private equity deals, as well as working with clients across the sector on domestic and international regulatory issues.” 

Asia-Pacific Legal500  

bottom of page